Avanos Medical Shares Fall As Higher Transportation Costs Hit Q2 Margins; Lowers FY21 Guidance

Loading...
Loading...
  • Avanos Medical Inc AVNS reported a second-quarter FY21 adjusted EPS of $0.21, missing the consensus of $0.23.
  • The sales of $186.4 million increased 14% Y/Y, beating the analyst estimate of $180.6 million.
  • Adjusted gross margin of 51.3% contracted from 55.7% last year primarily due to higher freight costs and inefficiencies at manufacturing plants.
  • It posted a wider operating loss of $(7) million compared to $2 million a year ago due to non-cash restructuring costs. Operating profit totaled $15 million on an adjusted basis, compared to $13 million a year ago. 
  • Adjusted EBITDA for Q2 was $20 million, compared to $19 million in the prior year.
  • FY21 guidance: Avanos said it expects to log adjusted EPS of $1.10 - $1.20, cutting the top half from its previous projection of $1.10 to $1.25. 
  • It projects a revenue increase of between 2% and 4%.
  • Price Action: AVNS shares are down 3.83% at $37.03 during the market session on the last check Tuesday.
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceShort IdeasHealth CareSmall CapMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...